Carmine Therapeutics Company
Carmine Therapeutics is developing novel types of gene therapies that utilize extracellular vesicles (EVs) produced in the laboratory.
Industry:
Gene Therapy
Technology:
Cardiovascular Disorders
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2019